Description: 92 page document, including 5 appendices and 175 references. This guideline comprises two main sections. The first (pp 5-14) provides non-referenced clinical practice guidelines which provide information about Parkinson's disease (PD), diagnostic processes (eg. outcome measures), and therapeutic processes. The second section (pp 14-49) provides a review of the evidence relating to PD aetiology, diagnosis, and prognosis; working party recommendations for the use of outcome measures in clinical practice; and a review of the evidence available regarding therapeutic processes. This latter section includes general treatment principles and evidence for specific treatment strategies, such as cueing strategies, improvement of gait, and falls prevention. A guide to the grading of the recommendations according to level of evidence is provided on p. 16. The document finishes with appendices that provide useful information about medications used in PD, 14 appendices of the measuring instruments recommended by the working party for use in PD (eg, Freezing of Gait questionnaire, Modified Parkinson's Activity Scale) and provides examples of cognitive movement strategies.
The University of Queensland
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Appraisal: Clinical Practice Guidelines|
|Publication:||Australian Journal of Physiotherapy|
|Date:||Dec 1, 2007|
|Previous Article:||Quantitative Ultrasound (QUS).|
|Next Article:||Acute pain.|